Goldman Sachs upgraded Hologic (NASDAQ: HOLX) from Buy to Conviction Buy with a price target of $47.00 (from $46.00). Analsyt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE